Boltz PBC Teams with Takeda to Deploy AI‑Driven Drug Discovery Platform Across Research Labs
Boltz PBC — the public‑benefit AI research lab behind the BoltzMol‑1 and BoltzProt‑1 foundation models — has announced a strategic partnership with Takeda to roll out its AI‑driven platform across the pharmaceutical giant’s research organization, giving scientists direct access to cutting‑edge biomolecular models for structure prediction, affinity estimation and generative design. What the partnership entails The collaboration grants Takeda’s discovery…
